Pharmaceutical Contract Packaging Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 15.25 Bn

Forecast Year, 2035

USD 31.79 Bn

CAGR, 2026 - 2035

7.62%

Report Coverage

Global

What is the Pharmaceutical Contract Packaging Market Size?

The global pharmaceutical contract packaging market size is calculated at USD 15.25 billion in 2025 and is predicted to increase from USD 16.43 billion in 2026 to approximately USD 31.79 billion by 2035, expanding at a CAGR of 7.62% from 2026 to 2035. The pharmaceutical contract packaging market is driven by the expansion of the global pharmaceutical industry and growth in generic drug production.

Pharmaceutical Contract Packaging Market Key Takeaways

• North America led the global market with the highest market share of 36% in 2025.
• By Product, the primary packaging segment has held the largest market share in 2025.
• By Material, the glass segment captured the biggest revenue share of 35% in 2025.

Market Overview

The pharmaceutical packaging of drugs is a vital facet, as the product requires being harmless to the patient. The requirement for speciality packaging has boosted an alternate industry that is contract manufacturing, which is now emerging progressively. Major pharma companies are now subcontracting the task of packaging the end product to those companies that are accomplished and dedicated to handling the packaging of medicines. Growth in the number of elderly populations, stringent norms on packaging by governing agencies and rising public interest in modernised packaging are certain of the influences that will boost the growth of the pharmaceutical contract packaging market across the world.

Pharmaceutical Contract Packaging Market Growth Factors

Pharmaceutical packaging of drugs is a vital facet as the product requires being harmless for patient. Requirement of specialty of packaging has boost up an alternate industry that is contract manufacturing that is being now emerging progressively. Major pharma companies are now subcontracting the task of packaging of end product to those companies who are accomplished and dedicated in handling packaging of medicines. Growth in number of elderly populations, stringent norms on packaging by governing agencies and rising public interest for modernized packaging are certain of the influences which will boost growth of pharmaceutical contract packaging market across the world.

Growth in the pharmaceutical sector will drive the need for pharmaceutical packaging in the marketplace. There is upsurge in the requirement for the drug delivery devices and blister packaging which is also predictable to augment the growth of the market. Intensifying health consciousness and swelling burden on the pharma firms for reduction of the cost is additional reason which is anticipated to further accelerate the growth of the market. Budding over the counter market will also fuel the market growth. Increasing demand for better healthcare facilities will also accelerate the market growth.

• Producing tailored and innovative packaging has uncertainties, henceforth, R&D spending in invention is challenging, which is inspiring pharmaceutical producers to elect for contract packaging services that have capable know-how and mandatory infrastructure. The growing production of low-priced generic medicines of branded drugs at the time of patent expiration is projected to bolster the demand for pharmaceutical contract packaging worldwide.
• The pharmaceutical contract packaging market is growing due to an upsurge in the requirement for drug delivery devices and blister packaging, which is also expected to augment the growth of the market.
  Producing tailored and innovative packaging has uncertainties, henceforth, R&D spending in invention is challenging, which is inspiring pharmaceutical producers to elect for contract packaging services that have capable know-how and mandatory infrastructure.
• The growing production of low-priced generic medicines of branded drugs at the time of patent expiration is projected to bolster the demand for pharmaceutical contract packaging worldwide.

Pharmaceutical Contract Packaging Market Outlook: Opportunities Ahead

• Industry Growth Overview: The growth in the outsourcing trends by the pharmaceutical companies to specialized third parties in order to manage regulatory complexities, assess expertise for specialized products like biologics, and cost control is driving the industrial growth in the market.
• Sustainability Trends: The sustainability trend focuses on the use of recyclable, biobased, and biodegradable mono materials to reduce material waste, and the integration of smart technology for minimizing spoilage and ensuring adherence to regulatory standards and patient safety.
• Major Investors: Large private equity firms are the major investors who are acquiring and collaborating with contract packaging organizations (CPOs) and CDMOs to develop global integrated service platforms. KKR, Blackstone, and Advent International are some of the major investors.

Market Scope

Market Dynamics

Driver

Rising Pharmaceutical Outsourcing

The increasing outsourcing of packaging operations by pharmaceutical and biotechnology companies is a major driver of the pharmaceutical contract packaging market. The manufacturers prefer contract packaging to reduce operational costs and improve production flexibility. Contract packaging organizations offer advanced packaging solutions such as serialisation, tamper evident packaging and cold chain solutions, regulatory compliance and cost effective processes, allowing pharmaceutical firms to enhance their supply chains and minimise operational complexities.

Restraint

Strict Regulatory Compliance Requirements

Stringent regulatory requirements remain a significant challenge for the pharmaceutical contract packaging market. Service providers must comply with evolving regulations set by health authorities and regulatory agencies, including Food Manufacturing Practices (GMP), serialisation, labelling precision, and product traceability. Meeting these requirements demands continuous investment in quality systems, employee training, validation and documentation. The growing complexity of biologics and speciality pharmaceuticals further requires specialised packaging. Smaller contract packaging companies often face higher compliance costs, which limit market expansion.

Opportunity

Growing Demand for Biologics and Specialty Medicines

The rapid growth of biologics, specialty drugs and personalized medicines presents a strong opportunity for pharmaceutical contract packaging providers. These products require sepcialized packaging solutions, including temperature controlled packaging, high barrier materials, and precise labelling to maintain product integrity throughout the distribution. The rising concerns of counterfeit pharmaceuticals are driving investments in advanced packaging solutions.

Segment Insights

Product Insights

Why has the Primary Packaging Segment dominated the Pharmaceutical Contract Packaging Market?

The primary packaging segment held a dominant position in the market in 2025 because it comes into direct contact with medicines and plays a critical role in maintaining product stability, sterility, and safety. The primary packaging is further classified into vials, bottles, blister packs, ampoules and others. This type of packaging is estimated to govern the global pharmaceutical contract packaging market during the coming years, owing to the cumulative outsourcing of primary packaging activities because of the deficiency of in-house competencies and capacities. Rising production of biologics and injectable drugs increases demand for high quality primary packaging to protect medicines.

The secondary packaging segment is expected to grow at the fastest CAGR during the studied period in the pharmaceutical contract packaging market. The secondary packaging is widely used to protect pharmaceutical products during transportation, improve product presentation, and ensure regulatory compliance. Contract packaging providers offer services such as labelling, serialization, carton packaging and tamper evident sealing. The secondary packaging is used to convey key information such as instructions for dosage, expiry date and other informative leaflets. The digital printing technologies are improving accuracy, speed, and traceability across the pharmaceutical packaging.

Material Insights

What made the Glass Segment Lead the Pharmaceutical Contract Packaging Market?

The glass segment registered its dominance over the global market in 2025 because of its excellent chemical resistance, impermeability, and ability to preserve drug stability. The glass packaging is widely used for injectable drugs, vaccines, and biologics. The growth is attributed to mid sized and small pharmaceutical companies that do not possess glass wrapping abilities. Further, low-priced service offered by the Development and Manufacturing Organizations (CDMOs) and Contract Packaging Organizations (CPOs) for pharmaceutical glass wrapping are likely to spur the market.

The Plastics and polymers segment is expected to witness the fastest growth in the pharmaceutical contract packaging market with a CAGR over the forecast period. The segment is growing due to the rising demand for plastic packaging in the pharmaceutical sector for the delivery and storage of medicines. The requirement for plastic bottles is rising in the pharmaceutical sector. The advantage of plastic bottles offers the bypassing of the requirement for tertiary packaging and safeguards the safety of the pharmaceutical product through the supply chain. Ophthalmic, syrups, and nasal medicines are frequently packed in plastic bottles.

Regional Insights

What Factors Made the North America Region the Dominant Region in the Market?

North America dominated the pharmaceutical contract packaging market in 2025, driven by increasing outsourcing from pharmaceutical and biotechnological companies, rising demand for biologics, and strict regulatory requirements. The presence of a large number of leading market players, such as Recipharm, Ropack Inc., Reed-Lane Inc., Jones Healthcare Group, Almac Group Limited, and others, is expected to contribute prominently towards the growth of the region. Robust research and development, and the existence of vital global participants in pharmaceutical drug manufacturing in North America, are reinforcing the contract pharmaceutical packaging outlook in the region.

U.S. Pharmaceutical Contract Packaging Market Size and Growth 2026 to 2035

The U.S. pharmaceutical contract packaging market size is valued at USD 3.84 billion in 2025 and is expected to be worth around USD 8.08 billion by 2035, at a CAGR of 7.72% from 2026 to 2035.

U.S. Market Trends

The United States represents the largest share of the pharmaceutical contract packaging market in North America. The growth is due to its extensive pharmaceutical manufacturing base and high outsourcing rates. The country has stringent regulatory guidelines, including FDA guidelines, the Drug Supply Chain Security Act (DSCSA), and Good Manufacturing Practices (GMP), encourages the manufactures to outsource the complex packaging operations. The country's leadership in innovative drugs, generic medicines, and biologics continues to generate demand for technology driven packaging services.

Why Asia Pacific is the Fastest-Growing Pharmaceutical Contract Packaging Market

On the other hand, the Asia Pacific market is observed to expand at a rapid pace during the forecast period due to several factors, including increasing investment in the healthcare infrastructure, growing healthcare demand, rise in healthcare expenditures, increasing incidence of chronic diseases, and increasing outsourcing of services. The region has advanced technology and large-scale manufacturing capabilities, driving the market's revenue growth. The region's robust presence of the pharmaceutical industry, which relies heavily on contract packaging services to cater to the evolving domestic and international needs. Such factors are contributing to the market's growth in the region during the forecast period.

Expanding Manufacturing: The Key Driver in China

The expanding pharmaceutical manufacturing and strict regulation are increasing the demand for pharmaceutical contract packaging solutions. At the same time, the growing use of advanced therapies and products is increasing their use, where their growing exports are also contributing to the same. The government initiatives are also supporting these advancements.

Specialized Packaging Solutions Transforming Europe

Europe is expected to grow significantly in the pharmaceutical contract packaging market during the forecast period, due to growing demand for specialized packaging due to increasing development and transportation of biologics, biosimilars, and personalized medicines. At the same time, the growth in R&D is increasing the outsourcing trends, leading to their increased demand. Additionally, the development of smart packaging solutions is also increasing, which is promoting the market growth.

Robust Industries Powers UK

The presence of robust pharmaceutical industries, focusing on pharmaceutical contract packing solutions, is increasing due to the growth in production rates. Additionally, the growing outsourcing trends, demand for biologics, and technological advancements are driving their demand, where advanced packaging solutions are also being developed by the companies.

What are the Advancements in the Market in Latin America?

Latin America held a considerable share of the pharmaceutical contract packaging market in 2025, supported by expanding pharmaceutical manufacturing and improved healthcare access. Pharmaceutical companies in the region are increasingly outsourcing packaging operations to improve efficiency, reduce costs, and comply with evolving regulatory standards. The increasing partnerships and mergers are further enhancing the industry's global reach. The demand for contract packaging is supported by expanding pharmaceutical distribution networks, the growing availability of generic medicines and rising investment from multinational companies.

Brazil Market Trends

Brazil accounts for the largest share of the Latin American pharmaceutical contract packaging market in 2025, due to its large domestic pharmaceutical industry and expanding healthcare sector. The country attracts multinational pharmaceutical companies looking for affordable outsourcing options for APIs, finished dosage forms and biologics. The country benefits from rising investment in advanced manufacturing technologies and supporting clinical research and trial activities. The rising consumption of generic medicines and government healthcare initiatives further support the market growth.

What are the Key Trends in the Market in the Middle East and Africa Region?

The Middle East & Africa held a notable share of the pharmaceutical contract packaging market in 2025, as governments strengthen domestic pharmaceutical, manufacturing and healthcare infrastructure. The countries, such as the UAE and Saudi Arabia, are investing in local drug production to reduce dependence on imported pharmaceutical products. The region also benefits from efforts to improve medicine accessibility and expand healthcare services. In the South Africa region, access to healthcare is gradually improving through international collaborations.

Saudi Arabia Market Trends

Saudi Arabia represents the leading market within the Middle East and Africa pharmaceutical contract packaging market in 2025, supported by government initiatives to develop domestic pharmaceutical manufacturing. The rising investment in pharmaceutical zones and advanced packaging technologies further drives demand for contract packaging services. The outsourcing services provide international compliance standards over the local facilities. The country focuses on strengthening healthcare security and attracting international pharmaceutical investments to create significant opportunities for contract packaging.

Driving Efficiency: Pharmaceutical Contract Packaging Market Value Chain Analysis

• Raw Material Sourcing: Raw materials like high-grade plastics, glass, aluminum foil, and paperboards are supplied from specialized suppliers in the raw material sourcing of pharmaceutical contract packing.
  Key players: Berlin Packaging, Schott AG, Bilcare Ltd, WestRock Co.
• Material Processing and Conversion: Material processing and conversion of raw materials of pharmaceutical contract packaging includes the conversion of raw materials like plastic pellets into bottles or plastic films and paperboard into injections, blister cavities, and folding cartons with the use of blow molding, cold-forming, or other processes.
  Key players: Gerresheimer AG, Bilcare Ltd., WestRock Co.
• Recycling and Waste Management: Recycling and waste management in the pharmaceutical contract packing includes segregation of hazardous and non-hazardous materials, where hazardous materials are incinerated and non-hazardous materials are chemically or mechanically recycled.
  Key players: Veolia, EcoVeda, Waste Management Inc., Bormioli Pharma.

Competitive Landscape

The pharmaceutical contract packaging market is highly competitive, with global and regional companies competing through service quality, regulatory compliance, packaging innovation and global reach. The leading companies in the market include SCHOTT AG, Wasdell Packaging Group, NIPRO, Amcor plc, West Pharmaceutical Services, Inc, and Constantia Flexible Group GmbH. Major players offer integrated solutions that include primary and secondary packaging, blister packaging, labelling, sterilisation, and logistic support. The compliance with the FDA (Food and Drug Administration), EMA (European Medicines Agency) and other international regulations remains a major aspect. The strategic partnerships, collaboration, and mergers are common approaches to maintain the market presence.

To strengthen the future growth in the pharmaceutical contract packaging market, companies should invest in smart packaging technologies, eco friendly materials and cold chain capabilities. The expansion of partnerships with pharmaceutical and biotechnological companies will support sustainable growth in the market.

The Competitive Innovators: Key Players' Offering

• SCHOTT AG: The company produces primary glass and polymer packaging components like ampoules, cartridges, vials, and prefilled syringes.
• WestRock Co.: Secondary and tertiary packaging solutions, line folding cartons, corrugated boxes, leaflets, paperboard packing, etc., are provided by the company.
• Bilcare Ltd.: Different types of blister packing materials and services are provided by the company, where it offers blister films, aluminum oils, and primary or secondary contract packaging services.
• CCL Industries Inc.: Packaging solutions, such as folding cartons and other healthcare packaging solutions, are offered by the company.
• Berlin Packaging: The company offers primary packaging components, dispensing systems, and value-added services like plastic bottles, vials, caps, etc.

Pharmaceutical Contract Packaging Market Companies

• AmerisourceBergen Corp.
• Becton, Dickinson and Co.
• Constantia Flexibles Group GmbH
• FedEx Corp.
• Others

Recent Developments

• In June 2026, Eisai, a Japanese pharmaceutical company, disclosed an investment, backed by the UK government through the Life Science Innovative Manufacturing Fund (LSIMF), to create supply chain and packaging capabilities for medications that require cold chain management. The company is investing approximately £48 million (US $ 63.5 million) at its Hatfield, UK site. This investment will enhance supply stability and flexibility by bringing more packaging operations in-house.

Segments Covered in the Report

By Product

• Primary Packaging
  • Ampoules
  • Bottles
  • Blister Packs
  • Others
• Secondary Packaging
• Tertiary Packaging

By Material

• Paper & Paperboard
• Plastics & Polymers
• Aluminum Foil
• Glass
• Others

By Regional Outlook

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa